Table 2 The laboratory findings for all the patients and the subgroup divided by family cluster.
Characteristics | All patient (Nā=ā37) | Familial cluster | ||
---|---|---|---|---|
Yes (Nā=ā21) | No (Nā=ā16) | P value | ||
Blood test | ||||
Ā White blood cell, Eā+ā09/L | 4.73 (3.90ā5.45) | 4.20 (3.69ā5.05) | 5.37 (4.54ā6.06) | 0.092 |
Ā Ā <ā4 | 11 (29.73%) | 8 (38.10%) | 3 (18.75%) | 0.202 |
Ā Ā ā„ā4, <ā10 | 26 (70.27%) | 13 (61.90%) | 13 (81.25%) | |
Ā Lymphocyte, Eā+ā09/L | 1.70 (1.20ā2.00) | 1.40 (1.00ā2.10) | 1.80 (1.70ā2.00) | 0.748 |
Ā Ā ā„ā0, <ā4 | 34 (91.89%) | 19 (90.48%) | 15 (93.75%) | 0.718 |
Ā Ā ā„ā4, <ā8 | 3 (8.11%) | 2 (9.52%) | 1 (6.25%) | |
Ā Neutrophils, Eā+ā09/L | 2.60 (2.00ā3.20) | 2.60 (2.00ā2.90) | 2.95 (2.10ā3.82) | 0.139 |
Ā Ā <ā2 | 9 (24.32%) | 5 (23.81%) | 4 (25.00%) | 0.238 |
Ā Ā ā„ā2, <ā7 | 26 (70.27%) | 16 (76.19%) | 10 (62.50%) | |
Ā Ā ā„ā7 | 2 (5.41%) | 0 (0.00%) | 2 (12.50%) | |
Ā Platelet, Eā+ā09/L | 188.00 (158.00ā238.00) | 165.00 (149.00ā205.00) | 228.00 (183.75ā238.75) | 0.194 |
Ā Ā <ā100 | 1 (2.70%) | 1 (4.76%) | 0 (0.00%) | 0.623 |
Ā Ā ā„ā100, <ā300 | 33 (89.19%) | 18 (85.71%) | 15 (93.75%) | |
Ā Ā ā„ā300 | 3 (8.11%) | 2 (9.52%) | 1 (6.25%) | |
Liver function | ||||
Ā Alanine aminotransferase (U/L) | 25.22 (24.01) 18.00 (14.00ā27.00) | 20.00 (15.00ā27.00) | 16.50 (13.00ā36.25) | 0.69 |
Ā Ā <ā40 | 34 (91.89%) | 20 (95.24%) | 14 (87.50%) | 0.393 |
Ā Ā ā„ā40 | 3 (8.11%) | 1 (4.76%) | 2 (12.50%) | |
Ā Aspartate aminotransferase (U/L) | 25.86 (14.34) 23.00 (19.00ā28.00) | 23.00 (19.00ā27.00) | 22.50 (18.75ā28.75) | 0.527 |
Ā Ā <ā40 | 34 (91.89%) | 19 (90.48%) | 15 (93.75%) | 0.718 |
Ā Ā ā„ā40 | 3 (8.11%) | 2 (9.52%) | 1 (6.25%) | |
Cardiac function | ||||
Ā Lactate dehydrogenase (U/L) | 212.00 (180.00ā275.00) | 227.00 (189.00ā275.00) | 202.00 (154.00ā256.75) | 0.458 |
Ā Ā <ā245 | 25 (67.57%) | 13 (61.90%) | 12 (75.00%) | 0.399 |
Ā Ā ā„ā245 | 12 (32.43%) | 8 (38.10%) | 4 (25.00%) | |
Ā Creatine kinase (U/L) | 97.98 (71.12) 84.10 (51.40ā106.90) | 88.00 (72.10ā153.70) | 57.40 (45.90ā94.88) | 0.657 |
Ā Ā <ā140 | 29 (78.38%) | 15 (71.43%) | 14 (87.50%) | 0.239 |
Ā Ā ā„ā140 | 8 (21.62%) | 6 (28.57%) | 2 (12.50%) | |
Ā Creatine kinase isoenzymes (U/L) | 14.00 (12.00ā22.00) | 16.00 (13.00ā24.00) | 13.50 (11.75ā17.00) | 0.494 |
Ā Ā <ā25 | 31 (83.78%) | 16 (76.19%) | 15 (93.75%) | 0.151 |
Ā Ā ā„ā25 | 6 (16.22%) | 5 (23.81%) | 1 (6.25%) | |
Ā Myoglobin (U/L) | 15.00 (10.00ā25.00) | 17.00 (13.00ā29.00) | 12.50 (8.75ā16.25) | 0.08 |
Ā Ā <ā46 | 33 (89.19%) | 18 (85.71%) | 15 (93.75%) | 0.435 |
Ā Ā ā46 | 4 (10.81%) | 3 (14.29%) | 1 (6.25%) | |
Ā Type B natriuretic peptide (pg/mL) | 45.00 (31.00ā103.00) | 65.00 (45.00ā116.00) | 31.00 (19.00ā50.75) | 0.206 |
Ā Ā <ā125 | 29 (78.38%) | 16 (76.19%) | 13 (81.25%) | 0.711 |
Ā Ā ā„ā125 | 8 (21.62%) | 5 (23.81%) | 3 (18.75%) | |
Inflammatory factors | ||||
Ā Erythrocyte sedimentation rate (mm/h) | 15.78 (18.06) 10.00 (3.00ā20.00) | 14.90 (19.44) 7.00 (4.00ā20.00) | 16.94 (16.63) 14.50 (2.00ā21.25) | 0.74 |
Ā Ā <ā20 | 27 (72.97%) | 15 (71.43%) | 12 (75.00%) | 0.809 |
Ā Ā ā„ā20 | 10 (27.03%) | 6 (28.57%) | 4 (25.00%) | |
Ā Interlekin 6 (pg/mL) | 12.36 (10.23) 9.01 (3.11ā19.84) | 13.39 (10.67) 10.56 (3.45ā19.93) | 11.02 (9.78) 7.34 (2.66ā19.13) | 0.492 |
āĀ Ā <ā7 | 16 (43.24%) | 8 (38.10%) | 8 (50.00%) | 0.469 |
Ā Ā ā„ā7 | 21 (56.76%) | 13 (61.90%) | 8 (50.00%) | |
Ā Procalcitonin (ng/mL) | 0.05 (0.03) 0.04 (0.03ā0.05) | 0.04 (0.02) 0.04 (0.03ā0.05) | 0.05 (0.04) 0.04 (0.02ā0.07) | 0.135 |
Ā Ā <ā0.05 | 26 (70.27%) | 16 (76.19%) | 10 (62.50%) | 0.367 |
Ā Ā ā„ā0.05 | 11 (29.73%) | 5 (23.81%) | 6 (37.50%) | |
Ā C-reactive protein (mg/L) | 12.51 (21.53) 3.31 (0.56ā12.00) | 3.20 (0.27ā10.20) | 3.67 (0.63ā14.05) | 0.214 |
Ā Ā <ā8.2 | 24 (64.86%) | 15 (71.43%) | 9 (56.25%) | 0.338 |
Ā Ā ā„ā8.2 | 13 (35.14%) | 6 (28.57%) | 7 (43.75%) | |
Ā Ferritin (U/L) | 122.50 (74.20ā345.40) | 87.63 (62.61ā325.80) | 200.95 (92.53ā456.07) | 0.043 |
Ā Ā <ā400 | 30 (81.08%) | 19 (90.48%) | 11 (68.75%) | 0.095 |
Ā Ā ā„ā400 | 7 (18.92%) | 2 (9.52%) | 5 (31.25%) |